Back to Franklin Templeton Inc. Franklin Templeton Inc.

ABVXABVX

Showing 8 of 11 quarters

Position history for Franklin Templeton Inc.Franklin Templeton Inc.'s holdings in Abivax SA

Yes. Franklin Templeton holds 299,754 shares of ABVX (Abivax), worth $39.9M, as of its Q2 2026 13F filing. It reduced the position by 83,076 shares (-21.7%) from Q1 2026. Franklin Templeton has held ABVX since Q4 2023, across 11 quarterly 13F filings.

Current Value

$39.9M

Current Shares

299,754

Total Value Change

+$27.3M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
299,754
-21.7%
$39.9M0.0%$133.26
0
2026-Q1
Decreased
382,830
-14.8%
$42.6M0.0%$111.35
0
2025-Q4
Decreased
449,121
-13.0%
$60.6M0.0%$134.86
0
2025-Q3
Decreased
516,090
-62.4%
$43.8M0.0%$84.90
0
2025-Q2
Unchanged
1.4M
0.0%
$10.5M0.0%$7.65
0
2025-Q1
Decreased
1.4M
-6.5%
$8.6M0.0%$6.25
0
2024-Q4
Increased
1.5M
+10.7%
$10.7M0.0%$7.32
31
2024-Q3
Decreased
1.3M
-5.1%
$12.6M0.0%$11.60
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used